# FDA Inspection 824161 - TriRx Huntsville Pharmaceutical Services, LLC - March 21, 2013

Source: https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/259d905f-1bb1-47fe-acfb-9235528ead4a
Source feed: FDA_Inspections

> FDA Inspection 824161 for TriRx Huntsville Pharmaceutical Services, LLC on March 21, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 824161
- Company Name: TriRx Huntsville Pharmaceutical Services, LLC
- Inspection Date: 2013-03-21
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1216782 - 2023-08-11](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/3b33daf8-bfa6-437e-9d8f-1611b733a98f)
- [FDA Inspection 1166895 - 2022-04-01](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/3f8dc216-6d17-4b5b-a74a-14052c6e9579)
- [FDA Inspection 978625 - 2016-04-21](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/89ab6faa-5411-4e35-966a-c29e63d3031b)
- [FDA Inspection 908381 - 2014-12-19](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/0fc0cd41-2f65-4177-ad00-19793dfbefed)
- [FDA Inspection 891076 - 2014-08-01](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/2d1caa8e-ca78-44d1-9156-75f72a2a356a)

Company: https://www.keypedia.com/companies/trirx-huntsville-pharmaceutical-services-llc/bdf3220b-2a57-4125-b4ef-af4d1d9c9fa8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c